Singapore markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
344.06+10.57 (+3.17%)
At close: 04:00PM EST
341.50 -2.56 (-0.74%)
After hours: 07:59PM EST
Sign in to post a message.
  • N
    $ABUS conversation
    mRNA based Covid vaccine, developed by $MRNA and $BNTX & $PFE, is just the beginning. There would be a lot more medical treatments available using the same tech. Patents are licensed to Genevant Sciences. This is why $ABUS had the standing in the courts, and $ABUS was defending its intellectual property. Not only Arbutus still own about 20% of Genevant, it would also get licensing fees from Genevant.
  • C
    Chris S
  • M
    Covboost study is out in Lancet.
    mRNA vaccine (Moderna and BNTX) is superior to boost.
    NVAX is OK but not better by any mains, perhaps worse on some measures.
    Explains UK decisions on boosting program fully.
  • A
    I'm proud of BNTX and proud of holding its shares.
  • n
    big jump in US cases yesterday. On the surface that should be good for us, but many antivaxxers will point to the vaccines not working. Even some on the fence of taking the booster may hold off or wait to there's one specific to omicron. I do believe our stock could explode if we can quickly show data that 3 shots keeps you safe or getting mild/moderate covid and having a variant dosage ready to go early next year. Orders could come in quickly.
  • L
    UK study finds mRNA COVID-19 vaccines provide biggest booster impact
  • D
    About Bancil and his executives selling hundreds of millions of dollars in options and rights offerings of Moderna. In my other life I was an officer in a NASDAQ listed company with thousands of qualified options in my name. I spent every dime I could spare to buy more shares in the open market. I was paid well, just as our stockholders when the company was acquired. If you are not willing to eat your own cooking there is something wrong with your recipe.
  • T
    Money should gradually flow from NVAX and MRNA to BNTX - the most optimal, scaleable and adaptable vaccine with established global footprints.
  • G
    Breaking News: Jerusalem Post (Israel) reports BNTX COVID Vaccine with booster is 93 percent effective against the Omicron Variant.
  • G
    Short term share price does not matter - look at fundamentals -
    There is a global press to get vaccine in hands of Nations - Who can delvier product?
    There is a global press to get boosters in Nations that have excess vaccine - Who has delivered the product
    There is a global press to get Children vaccinated - Who has and delviered the product

    Now there will likely be a new vaccine coming its in the new orders ie the UK has faith that the best solution is mRNA - Australia HM said it yesterday same thing - mRNA will be their vaccine of choice. US said it, EU said it and they have ordered hundreds of mlns.

    Now only thing holding us back is the people need to start taking their medicine.

    But 2022 is clearly now a growth year in revnue - and 2023 orders are coming in now too. UK, Canada, EU (will excercise their option once new vaccine is avialble) -

    Once the new storgage version is out the USG will pump 800mln doses into African Nations - Help is on the way it just takes some time.
  • G
    BioNTech (BNTX) is capable of modifying its COVID-19 vaccine relatively quickly to adapt to the new omicron variant, which has generate
  • J
    CNBC discussion of equitable distribution, how to get it right this time: only discussion of $mrna and $bntx. Absolutely no mention of $nvax or any other vaxes for that matter. And no mention of lancet booster study.
  • R
    Get ready tomorrow is gonna be a good day, Green all day👍😎.
  • G
    But within a month or so, Pfizer says it will roll out a new formulation of the vaccine that can be stored for three months in a fridge, which Dr Bourla said, would make a "huge difference" for sub-Saharan African countries.
  • B
    Got my BioNTech booster today :-)
  • H
    BNTX will always be king
  • H
    hedge funds causing selling panic in morning markets only to buy cheap in afternoon sigh
  • K
    bottom line is yearly booster for the foreseeable future .. BioNTech will have the Cash to build the Biggest mRNA Biotech Company in The World .. BNTX $1000+
  • L
    Markets in general are keeping a lid on BNTX SP today. Pundits are still chattering incessantly about value vs growth vs fixed income vs safety. But merrily we will roll along.....knowing we have great products that can be properly tweaked when necessary, a strong distribution partner in Pfizer, unbelievably brilliant, devoted, and determined scientific leadership, lots of bucks in the vault, quiet partnerships with the best bioscientific companies, and a legitimate oncology pipeline that is without peer.

    "Sine Pari" as the Romans used to say.